2,018 Shares in Cardinal Health, Inc. (NYSE:CAH) Bought by Atomi Financial Group Inc.

Atomi Financial Group Inc. bought a new position in Cardinal Health, Inc. (NYSE:CAH) during the fourth quarter, according to its most recent disclosure with the SEC. The firm bought 2,018 shares of the company’s stock, valued at approximately $239,000.

A number of other institutional investors also recently bought and sold shares of the stock. State Street Corp raised its holdings in Cardinal Health by 4.6% in the 3rd quarter. State Street Corp now owns 14,177,641 shares of the company’s stock worth $1,566,913,000 after purchasing an additional 627,253 shares during the period. Geode Capital Management LLC raised its holdings in Cardinal Health by 0.7% in the 3rd quarter. Geode Capital Management LLC now owns 5,749,859 shares of the company’s stock worth $633,298,000 after purchasing an additional 42,082 shares during the period. Pacer Advisors Inc. raised its holdings in Cardinal Health by 4.7% during the third quarter. Pacer Advisors Inc. now owns 4,290,650 shares of the company’s stock valued at $474,203,000 after acquiring an additional 191,568 shares during the period. Charles Schwab Investment Management Inc. raised its holdings in Cardinal Health by 2.3% during the third quarter. Charles Schwab Investment Management Inc. now owns 1,474,625 shares of the company’s stock valued at $162,976,000 after acquiring an additional 33,388 shares during the period. Finally, Brandes Investment Partners LP raised its holdings in Cardinal Health by 10.1% during the second quarter. Brandes Investment Partners LP now owns 1,315,316 shares of the company’s stock valued at $129,439,000 after acquiring an additional 121,107 shares during the period. 87.17% of the stock is owned by institutional investors.

Cardinal Health Trading Down 0.3 %

CAH opened at $128.89 on Monday. The firm has a market cap of $31.19 billion, a P/E ratio of 25.08, a P/E/G ratio of 1.57 and a beta of 0.63. Cardinal Health, Inc. has a 12 month low of $93.17 and a 12 month high of $129.68. The stock has a 50-day moving average of $121.36 and a 200 day moving average of $113.16.

Cardinal Health (NYSE:CAH) last released its quarterly earnings results on Friday, November 1st. The company reported $1.88 EPS for the quarter, topping the consensus estimate of $1.62 by $0.26. The company had revenue of $52.28 billion during the quarter, compared to analyst estimates of $50.90 billion. Cardinal Health had a negative return on equity of 56.56% and a net margin of 0.56%. The firm’s revenue was down 4.3% on a year-over-year basis. During the same quarter last year, the business posted $1.73 earnings per share. On average, research analysts forecast that Cardinal Health, Inc. will post 7.82 earnings per share for the current fiscal year.

Cardinal Health Cuts Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, January 15th. Shareholders of record on Thursday, January 2nd were paid a $0.5056 dividend. This represents a $2.02 annualized dividend and a yield of 1.57%. The ex-dividend date of this dividend was Thursday, January 2nd. Cardinal Health’s payout ratio is currently 39.30%.

Analyst Upgrades and Downgrades

CAH has been the topic of a number of recent analyst reports. TD Cowen raised Cardinal Health from a “hold” rating to a “buy” rating and raised their price target for the company from $130.00 to $144.00 in a report on Wednesday, January 8th. Evercore ISI raised Cardinal Health from an “in-line” rating to an “outperform” rating and set a $140.00 price target on the stock in a report on Tuesday, January 7th. Wells Fargo & Company raised Cardinal Health from an “underweight” rating to an “equal weight” rating and raised their price target for the company from $101.00 to $127.00 in a report on Friday, December 13th. StockNews.com cut Cardinal Health from a “strong-buy” rating to a “buy” rating in a report on Sunday, November 3rd. Finally, Mizuho started coverage on Cardinal Health in a report on Wednesday, December 4th. They set an “outperform” rating and a $139.00 price target on the stock. Four equities research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $134.64.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.